Apellis Pharmaceuticals, Inc. (APLS)

22.34 +0.06 (+0.27%) USD  |  NASDAQ  |  Feb 23, 13:27
More

Apellis Pharmaceuticals Other Long Term Liabilities (Quarterly)

Other Long Term Liabilities (Quarterly) Chart

View Other Long Term Liabilities (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Long Term Liabilities (Quarterly) Range, Past 5 Years

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Long Term Liabilities (Quarterly) Benchmarks

View Other Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade